Clinical Trial Update: Phase IV O2 Consumption Study in COPD Patients. [Phase 4]

View source ↗

Summary

Phase IV oxygen consumption study in COPD patients has completed and results were posted in 2018. The sponsor of the study is AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: COMPLETED | Results posted: 2018-07-30